Home/Aurobindo Pharma/Sanjay Kumar
SK

Sanjay Kumar

Chief Executive Officer, APUSA

Aurobindo Pharma

Aurobindo Pharma Pipeline

DrugIndicationPhase
US Generics PortfolioBroad Therapeutic AreasFiled/Approved
Biosimilars Pipeline (Oncology Focus)OncologyDevelopment
Biosimilars Pipeline (Immunology Focus)ImmunologyDevelopment
Complex Generics PipelineVariousDevelopment/Filed
ARV PortfolioHIV/AIDSCommercial